PERMROCK ROYALTY TRUST (PRT)

US7142541090

3.45  +0.05 (+1.47%)

Fundamental Rating

4

Taking everything into account, PRT scores 4 out of 10 in our fundamental rating. PRT was compared to 205 industry peers in the Oil, Gas & Consumable Fuels industry. No worries on liquidiy or solvency for PRT as it has an excellent financial health rating, but there are worries on the profitability. PRT has a expensive valuation and it also scores bad on growth.



3

1. Profitability

1.1 Basic Checks

In the past year PRT was profitable.
In the past 5 years PRT has always been profitable.
In the past 5 years PRT always reported negative operating cash flow.

1.2 Ratios

PRT has a better Return On Assets (8.11%) than 69.61% of its industry peers.
Looking at the Return On Equity, with a value of 8.15%, PRT is doing worse than 61.27% of the companies in the same industry.
PRT has a Return On Invested Capital (6.44%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for PRT is significantly below the industry average of 29.02%.
Industry RankSector Rank
ROA 8.11%
ROE 8.15%
ROIC 6.44%
ROA(3y)10.57%
ROA(5y)8.73%
ROE(3y)10.67%
ROE(5y)8.8%
ROIC(3y)8.43%
ROIC(5y)6.96%

1.3 Margins

PRT has a better Profit Margin (87.14%) than 96.57% of its industry peers.
In the last couple of years the Profit Margin of PRT has declined.
With an excellent Operating Margin value of 87.14%, PRT belongs to the best of the industry, outperforming 97.06% of the companies in the same industry.
In the last couple of years the Operating Margin of PRT has declined.
Industry RankSector Rank
OM 87.14%
PM (TTM) 87.14%
GM N/A
OM growth 3Y13.33%
OM growth 5Y-1.92%
PM growth 3Y13.33%
PM growth 5Y-1.92%
GM growth 3YN/A
GM growth 5YN/A

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, PRT has about the same amount of shares outstanding.
PRT has about the same amout of shares outstanding than it did 5 years ago.
PRT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

PRT has an Altman-Z score of 67.75. This indicates that PRT is financially healthy and has little risk of bankruptcy at the moment.
PRT has a better Altman-Z score (67.75) than 99.51% of its industry peers.
There is no outstanding debt for PRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 67.75
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

PRT has a Current Ratio of 3.71. This indicates that PRT is financially healthy and has no problem in meeting its short term obligations.
PRT has a Current ratio of 3.71. This is amongst the best in the industry. PRT outperforms 85.29% of its industry peers.
A Quick Ratio of 3.71 indicates that PRT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.71, PRT belongs to the best of the industry, outperforming 86.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.71
Quick Ratio 3.71

0

3. Growth

3.1 Past

The earnings per share for PRT have decreased strongly by -49.36% in the last year.
Measured over the past years, PRT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.66% on average per year.
Looking at the last year, PRT shows a very negative growth in Revenue. The Revenue has decreased by -45.48% in the last year.
Measured over the past years, PRT shows a very negative growth in Revenue. The Revenue has been decreasing by -15.05% on average per year.
EPS 1Y (TTM)-49.36%
EPS 3Y47.62%
EPS 5Y-16.66%
EPS Q2Q%-57.14%
Revenue 1Y (TTM)-45.48%
Revenue growth 3Y31.09%
Revenue growth 5Y-15.05%
Sales Q2Q%-55.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

PRT is valuated cheaply with a Price/Earnings ratio of 6.76.
Based on the Price/Earnings ratio, PRT is valued a bit cheaper than 77.45% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.73. PRT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.76
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.17%, PRT is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.08, PRT pays a better dividend. On top of this PRT pays more dividend than 89.71% of the companies listed in the same industry.
PRT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 11.17%

5.2 History

The dividend of PRT has a limited annual growth rate of 5.12%.
PRT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)5.12%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A

PERMROCK ROYALTY TRUST

NYSE:PRT (12/20/2024, 8:04:00 PM)

3.45

+0.05 (+1.47%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-12 2024-11-12
Earnings (Next)N/A N/A
Inst Owners1.88%
Inst Owner Change33.28%
Ins Owners0.07%
Ins Owner Change0%
Market Cap41.99M
Analysts45
Price Target2.04 (-40.87%)
Short Float %0.17%
Short Ratio0.25
Dividend
Industry RankSector Rank
Dividend Yield 11.17%
Dividend Growth(5Y)5.12%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date11-29 2024-11-29 (0.030271)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.76
Fwd PE N/A
P/S 5.84
P/FCF N/A
P/OCF N/A
P/B 0.55
P/tB 0.55
EV/EBITDA N/A
EPS(TTM)0.51
EY14.78%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.59
BVpS6.32
TBVpS6.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.11%
ROE 8.15%
ROCE 8.15%
ROIC 6.44%
ROICexc 6.56%
ROICexgc N/A
OM 87.14%
PM (TTM) 87.14%
GM N/A
FCFM N/A
ROA(3y)10.57%
ROA(5y)8.73%
ROE(3y)10.67%
ROE(5y)8.8%
ROIC(3y)8.43%
ROIC(5y)6.96%
ROICexc(3y)8.62%
ROICexc(5y)7.1%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.67%
ROCE(5y)8.8%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y56.18%
ROICexc growth 5Y-13.54%
OM growth 3Y13.33%
OM growth 5Y-1.92%
PM growth 3Y13.33%
PM growth 5Y-1.92%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.71
Quick Ratio 3.71
Altman-Z 67.75
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.36%
EPS 3Y47.62%
EPS 5Y-16.66%
EPS Q2Q%-57.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-45.48%
Revenue growth 3Y31.09%
Revenue growth 5Y-15.05%
Sales Q2Q%-55.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.1%
EBIT growth 3Y48.56%
EBIT growth 5Y-16.67%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A